-- （第二段和第三段新增加拿大国家银行评论，最后一段更新股价） 巴里克矿业公司（纽约证券交易所代码：B，多伦多证券交易所代码：ABX.TO）周二表示，公司已任命多位高管，并更新了其计划成立一家新公司并持有其北美黄金资产的少数股权的首次公开募股（IPO）计划。 对此，加拿大国家银行表示，其“跑赢大盘”评级维持不变，理由是巴里克目前的估值偏低、Fourmile项目未来的进展以及其北美资产即将实现的价值。“Fourmile项目的勘探进展是公司重要的价值驱动因素，鉴于此前宣布的马里Loulo-Gounkoto项目已得到解决，这进一步支持了公司估值的提升。随着公司重新聚焦于提高美洲（以内华达州为中心）的黄金产量，并持续改进运营，我们认为未来公司有望实现更可持续的估值倍数增长。”该银行补充道。 加拿大国家银行表示，其72.50加元的目标价是基于100%加权的6.50倍EV/2026E EBITDA目标倍数计算得出，这意味着其市净率（P/NAV）为1.07倍。该银行指出，巴里克黄金目前的EV/2026E EBITDA倍数为4.8倍，NAV倍数为0.78倍，而同业大型黄金公司的相应倍数分别为6.6倍和1.01倍。 巴里克黄金周二在一份声明中表示，公司已任命一支专门负责北美业务的高管团队。“他们已经成功合作数月。该团队由经验丰富、业绩卓著的巴里克资深人士组成，他们在运营、勘探和开发方面拥有深厚的专业知识。”声明补充道。 该团队向巴里克黄金总裁兼首席执行官马克·希尔汇报工作，成员包括：首席运营官蒂姆·克里布；首席财务官韦塞尔·哈曼；首席法务官兼公司秘书乔·赫肯多恩；首席技术官梅根·蒂博尔斯。首席人力资源官理查德·巴利 (Richard Barley)、勘探副总裁哈维尔·奥图扎尔 (Javier Ortuzar) 和可持续发展副总裁阿曼达·斯蒂恩森 (Amanda Steensen) 出席了发布会。 巴里克表示，北美巴里克公司将包含位于北美顶级矿业管辖区的四项一级黄金资产：内华达黄金矿区的卡林 (Carlin)、科尔特斯 (Cortez) 和绿松石岭 (Turquoise Ridge) 金矿，以及多米尼加共和国的普韦布洛维耶霍 (Pueblo Viejo) 金矿。预计到 2025 年，北美巴里克公司旗下资产的黄金产量约为 200 万盎司，归属于巴里克公司的权益。 北美巴里克公司还将包括巴里克公司全资拥有的位于内华达黄金矿区 (NGM) 附近的福迈尔 (Fourmile) 金矿项目。巴里克公司表示：“福迈尔金矿是本世纪最重要的黄金发现之一，并将成为北美巴里克公司资产组合中重要的高品位、低成本增长机会。预计福迈尔金矿最终将根据《内华达黄金矿区合资协议》并入内华达黄金矿区合资企业。” 巴里克公司表示，已确定其北美资产首次公开募股（IPO）的最佳结构。巴里克北美公司预计将在纽约进行主要上市，并在多伦多进行二次上市，但需通过美国证券交易委员会（SEC）的常规注册程序和加拿大招股说明书的资格审查。巴里克补充说，公司正按计划推进IPO，预计将于2026年底前完成，但需视市场和其他条件以及必要的审批情况而定。 公司预计，此次IPO将遵守巴里克合资协议中的所有适用承诺。“巴里克的领导层一直在与纽蒙特矿业公司（Newmont）的对口官员会面，讨论如何提升纽蒙特矿业公司的业绩、拟议的IPO以及Fourmile矿的出售时间表。虽然巴里克可以单方面推进IPO，但它正与合资伙伴密切合作，以确保为各方创造并最大化价值。” 巴里克股票昨日在加拿大下跌1.2%。该股昨日在美国交易时段下跌1%，截至美国盘前交易时段，下跌2%。
Related Articles
Sectors
Sector Update: Tech Stocks Fall Late Afternoon
Tech stocks fell late Tuesday afternoon, with the State Street Technology Select Sector SPDR ETF (XLK) dropping 1.5% and the State Street SPDR S&P Semiconductor ETF (XSD) slumping 4.4%.The Philadelphia Semiconductor index shed 3.3%.In corporate news, OpenAI recently missed its own targets for new users and revenue, the Wall Street Journal reported late Monday, citing people familiar with the matter. Tech bellwether Nvidia (NVDA) fell 1.2%, Broadcom (AVGO) dropped 4.2%, Advanced Micro Devices (AMD) shed 3.1%, Oracle (ORCL) lost 3.6%, and Intel (INTC) declined 1.4%.Lam Research (LRCX), Applied Materials (AMAT) and KLA (KLAC) were among the chip equipment companies believed to have received a letter last week from the US Department of Commerce ordering them to halt certain tool shipments to China's second-largest chipmaker Hua Hong, Reuters reported. Lam declined 3%, Applied Materials dropped 5.1%, and KLA shed 4.1%.Amazon.com (AMZN) plans to make OpenAI's artificial intelligence models available to its customers after Microsoft (MSFT) relinquished its exclusive rights to resell the ChatGPT maker's products, Bloomberg reported Tuesday, citing Amazon Web Services CEO Matt Garman in a Bloomberg Television interview. Amazon shares were down 0.6%, and Microsoft rose 0.6%.Spotify Technology (SPOT) reported stronger-than-expected Q1 profit, but its premium subscriber growth and outlook disappointed investors. The stock fell 12%.
$AMAT$AMD$AMZN$AVGO$INTC$KLAC$LRCX$MSFT$NVDA$ORCL$SPOT
Research
Research Alert: Paccar: Q1 Eps Match Expectations; Class-8 Outlook Reiterated
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PCAR's Q1 results matched consensus with operating EPS of $1.15 vs. $0.96 in the prior year, supported by the absence of litigation charges that impacted Q1 2025. New truck deliveries fell 7K units to 33.1K globally, with North American Class-8 shipments declining while Europe showed strength. The Parts business managed positive expansion despite truck sales softness, benefiting from strategic investments in distribution infrastructure. Management maintained an upbeat tone on customer demand trends, though their North American outlook for retail Class-8 truck sales remained unchanged from Q4. PCAR generated healthy operating cash flow of $972M vs. $910M and maintained a strong balance sheet, in our view. Management projected full-year capex of ~$750M and R&D expenses of ~$475M for next-generation powertrains. We see the unchanged shipment projections as a signal that management is not entirely confident an inflection is occurring stronger than previously anticipated.
$PCAR
Australia
Erasca Shares Fall After Preliminary Phase 1 Dose Escalation Data
Erasca (ERAS) shares fell 48% Tuesday after the company reported preliminary phase 1 dose-escalation data for its experimental ERAS-0015 in patients with RAS-mutant solid tumors, including colorectal cancer, non-small-cell lung cancer and pancreatic adenocarcinoma.The preliminary data, from ongoing trials in the US and China, suggest ERAS-0015 may be combined with standard-of-care doses of panitumumab, positioning it as a potential backbone therapy for future combination regimens, the company said.The therapy was generally "well tolerated," with no dose-limiting toxicities or treatment discontinuations due to adverse events, according to a statement.Erasca said it selected 24 mg and 32 mg once daily as recommended doses for further study and said the drug showed "promising clinical potential" for combination use with panitumumab.In a regulatory filing, the company said a patient, who was a 66 year-old male with heavily pretreated metastatic pancreatic adenocarcinoma, had died. The company said grade 3 treatment-related adverse events of pneumonitis progressed to grade 5 following withdrawal of supportive care per patient decision.Price: $9.96, Change: $-9.20, Percent Change: -48.02%
$ERAS